NewLab BioQuality GmbH is now a part of Charles River, a global contract research organization with offerings that span the entire drug development process, from discovery through market approval.
Charles River Biopharmaceutical Services (BPS) delivers client-focused solutions for the specific testing and manufacturing requirements of your biologic. Through the acquisition of NewLab, Charles River BPS has expanded its global footprint to provide you with even more flexibility, experience and expertise in multiple regulatory environments.

You should be automatically redirected to the Charles River website in 10 seconds.
If you are not automatically redirected, please click here.